| 000 | 01329 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517130154.0 | ||
| 264 | 0 | _c20170228 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a2211-0356 | ||
| 024 | 7 |
_a10.1016/j.msard.2016.09.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimula, Sakari | |
| 245 | 0 | 0 |
_aHeart rate variability predicts the magnitude of heart rate decrease after fingolimod initiation. _h[electronic resource] |
| 260 |
_bMultiple sclerosis and related disorders _cNov 2016 |
||
| 300 |
_a86-89 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aElectrocardiography, Ambulatory |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFingolimod Hydrochloride _xadverse effects |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdiagnosis |
| 650 | 0 | 4 | _aPrognosis |
| 700 | 1 | _aLaitinen, Tomi P | |
| 700 | 1 | _aLaitinen, Tiina M | |
| 700 | 1 | _aHartikainen, Päivi | |
| 700 | 1 | _aHartikainen, Juha Ek | |
| 773 | 0 |
_tMultiple sclerosis and related disorders _gvol. 10 _gp. 86-89 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.msard.2016.09.012 _zAvailable from publisher's website |
| 999 |
_c26668293 _d26668293 |
||